Abstract
Renal disease, including slight renal injuries, has come to be seen as one of the risk factors for cardiovascular events. At present, most conventional therapy is inefficient, and tends to treat the symptoms rather than the underlying causes of the disorder. Gene therapy based on oligonucleotides (ODN) offers a novel approach for the prevention and treatment of renal diseases. Gene transfer into somatic cells to interfere with the pathogenesis contributing to renal disease may provide such an approach, leading to the better prevention and treatment of renal disease. The major development of gene transfer methods has made an important contribution to an intense investigation of the potential of gene therapy in renal diseases. Amazing advances in molecular biology have provided the dramatic improvement in the technology that is necessary to transfer target genes into somatic cells. Gene transfer methods, especially when mediated by several viral vectors, have improved to a surprising extent. In fact, some (retroviral vectors, adenoviral vectors, or liposome-based vectors, etc.) have already been used in clinical trials. On the other hand, recent progress in molecular biology has provided new techniques to inhibit target gene expression. The transfer of cis-element double-stranded ODN (= decoy) has been reported to be a powerful novel tool in a new class of antigene strategies for gene therapy. The transfer of decoy ODN corresponding to the cis sequence will result in attenuation of the authentic cis–trans interaction, leading to the removal of trans-factors from the endogenous cis-elements with a subsequent modulation of gene expression.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
AG Papavassiliou (1998) ArticleTitleTranscription-factor-modulating agents: precision and selectivity in drug design Mol Med Today 4 358–66 Occurrence Handle9755455 Occurrence Handle10.1016/S1357-4310(98)01303-3 Occurrence Handle1:CAS:528:DyaK1cXlslWgt7o%3D
N Tomita R Morishita J Higaki T Ogihara (1997) ArticleTitleA novel strategy for gene therapy and gene regulation analysis using transcription factor decoy oligonucleotides Exp Nephrol 5 429–34 Occurrence Handle9386980 Occurrence Handle1:CAS:528:DyaK2sXnt1Kqtrs%3D
R Morishita J Higaki N Tomita T Ogihara (1998) ArticleTitleApplication of transcription factor “decoy” strategy as a means of gene therapy and study of gene expression in cardiovascular disease Circ Res 82 1023–8 Occurrence Handle9622154 Occurrence Handle1:CAS:528:DyaK1cXjslSjtro%3D
R Morishita H Nakagami Y Taniyama H Matsushita K Yamamoto N Tomita et al. (1998) ArticleTitleOligonucleotide-based gene therapy for cardiovascular disease Clin Chem Lab Med 36 529–34 Occurrence Handle9806454 Occurrence Handle10.1515/CCLM.1998.090 Occurrence Handle1:CAS:528:DyaK1cXmsFCjt78%3D
R Morishita M Aoki Y Kaneda (2000) ArticleTitleOligonucleotide-based gene therapy for cardiovascular disease: are oligonucleotide therapeutics novel cardiovascular drugs? Curr Drug Targets 1 15–23 Occurrence Handle11475534 Occurrence Handle10.2174/1389450003349344 Occurrence Handle1:CAS:528:DC%2BD3cXlt1Wht7c%3D
N Tomita R Morishita Y Kaneda J Higaki T Ogihara (2000) ArticleTitleGene therapy as a potential treatment for restenosis and myocardial infarction Drug News Perspect 13 206–12 Occurrence Handle12937625 Occurrence Handle1:CAS:528:DC%2BD3cXms1Ohur0%3D
N Tomita R Morishita T Tomita T Ogihara (2002) ArticleTitlePotential therapeutic applications of decoy oligonucleotides Curr Opin Mol Ther 4 166–70 Occurrence Handle12044038 Occurrence Handle1:CAS:528:DC%2BD38XlvVShsbw%3D
N Tomita T Ogihara R Morishita (2003) ArticleTitleTranscription factors as molecular targets: Molecular mechanism of decoy ODN and their design Curr Drug Targets 4 603–8 Occurrence Handle14577649 Occurrence Handle10.2174/1389450033490803 Occurrence Handle1:CAS:528:DC%2BD3sXotFKls7Y%3D
N Tomita T Ogihara R Morishita (2003) ArticleTitleTherapeutic potential of decoy oligonucleotides strategy in cardiovascular disease Expert Rev Cardiovas Ther 1 463–70 Occurrence Handle10.1586/14779072.1.3.463 Occurrence Handle1:CAS:528:DC%2BD3sXotVensrs%3D
R Morishita N Tomita Y Kaneda T Ogihara (2004) ArticleTitleMolecular therapy to inhibit NF kappa B activation by transcription factor decoy oligonucleotides Curr Opin Pharmacol 4 139–46 Occurrence Handle15063357 Occurrence Handle10.1016/j.coph.2003.10.008 Occurrence Handle1:CAS:528:DC%2BD2cXivVClu7Y%3D
R Morishita GH Gibbons KE Ellison M Nakajima L Zhang Y Kaneda et al. (1995) ArticleTitleA gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo Proc Natl Acad Sci USA 92 5855–9 Occurrence Handle7597041 Occurrence Handle10.1073/pnas.92.13.5855 Occurrence Handle1:CAS:528:DyaK2MXmsFWqt74%3D
R Morishita J Higaki N Tomita M Aoki A Moriguchi K Tamura et al. (1996) ArticleTitleRole of transcriptional cis-elements, angiotensinogen gene-activating elements, of the angiotensinogen gene in blood pressure regulation Hypertension 27 502–7 Occurrence Handle8613193 Occurrence Handle1:CAS:528:DyaK28Xit1Gju7g%3D
R Morishita T Sugimoto M Aoki I Kida N Tomita A Moriguchi et al. (1997) ArticleTitleIn vivo transfection of the cis element “decoy” against the nuclear factor-kappa B binding site prevents myocardial infarction Nat Med 3 894–9 Occurrence Handle9256281 Occurrence Handle10.1038/nm0897-894 Occurrence Handle1:CAS:528:DyaK2sXltVOhs7g%3D
N Tomita M Horiuchi S Tomita GH Gibbons JY Kim D Baran et al. (1998) ArticleTitleA novel strategy transcription factor decoy for E2F inhibits proliferation in mesangial cells in vitro Am J Physiol 27 F278–84
T Tomita E Takeuchi N Tomita R Morishita M Kaneko K Yamamoto et al. (1999) ArticleTitleIn vivo transfection of NF-κB decoy ODN suppressed the severity of rat collagen-induced arthritis as a gene therapy Arthritis Rheum 42 2535–42 Occurrence Handle10.1002/1529-0131(199912)42:12<2532::AID-ANR5>3.0.CO;2-2
N Tomita R Morishita HY Lan K Yamamoto M Hashizume M Notake et al. (2000) ArticleTitleIn vivo administration of a nuclear transcription factor-kappa B decoy suppresses experimental crescentic glomerulonephritis J Am Soc Nephrol 11 1244–52 Occurrence Handle10864580 Occurrence Handle1:CAS:528:DC%2BD3cXltFOjur8%3D
N Tomita R Morishita S Tomita GH Gibbons L Zhang M Horiuchi et al. (2000) ArticleTitleTranscription factor decoy for NF kappa B inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo Gene Ther 7 1326–32 Occurrence Handle10918504 Occurrence Handle10.1038/sj.gt.3301243 Occurrence Handle1:CAS:528:DC%2BD3cXlsVels7c%3D
N Tomita R Morishita K Yamamoto J Higaki VJ Dzau T Ogihara et al. (2001) ArticleTitleTargeted gene therapy for rat glomerulonephritis using HVJ-immunoliposomes J Gene Med 4 527–35 Occurrence Handle10.1002/jgm.300 Occurrence Handle1:CAS:528:DC%2BD38XosVWrurc%3D
K Yamasaki T Asai M Shimizu M Aoki N Hashiya H Sakonjo et al. (2003) ArticleTitleInhibition of NF kappa B activation using a cis-element “decoy” of NF kappa B binding site reduces neointimal formation in a porcine balloon-injured coronary artery model Gene Ther 10 356–64 Occurrence Handle12595894 Occurrence Handle10.1038/sj.gt.3301875 Occurrence Handle1:CAS:528:DC%2BD3sXhtlWisLk%3D
N Tomita JY Kim GH Gibbons L Zhang Y Kaneda RA Stahl et al. (2004) ArticleTitleGene therapy with E2F transcription factor decoy inhibits cell cycle progression in anti-Thy 1 glomerulonephritis Int J Mol Med 13 629–36 Occurrence Handle15067361 Occurrence Handle1:CAS:528:DC%2BD2cXjvFyjurY%3D
H Nakashima M Aoki T Miyake T Kawasaki M Iwai N Jo et al. (2004) ArticleTitleInhibition of experimental abdominal aortic aneurysm in the rat by use of decoy oligodeoxy-nucleotides suppressing activity of nuclear factor kappa-B and ets transcription factors Circulation 109 132–8 Occurrence Handle14662712 Occurrence Handle10.1161/01.CIR.0000105725.61763.A2 Occurrence Handle1:CAS:528:DC%2BD3sXhtVWjtrjE
SJ Weintraub C Prater DC Dean (1992) ArticleTitleRetinoblastoma protein switches the E2F site from positive to negative element Nature 358 259–61 Occurrence Handle1321348 Occurrence Handle10.1038/358259a0 Occurrence Handle1:CAS:528:DyaK38XltVGlsrs%3D
DS Latchman (1996) ArticleTitleTranscription-factor mutations and disease N Engl J Med 334 28–33 Occurrence Handle7494569 Occurrence Handle10.1056/NEJM199601043340108 Occurrence Handle1:STN:280:DyaK287gsFarsQ%3D%3D
T Yamada M Horiuchi R Morishita L Zhang RE Pratt VJ Dzau (1995) ArticleTitleIn vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer J Clin Invest 96 1230–7 Occurrence Handle7657796 Occurrence Handle1:CAS:528:DyaK2MXnvVGqtrg%3D Occurrence Handle10.1172/JCI118156
S Tomita N Tomita T Yamada L Zhang Y Kaneda R Morishita et al. (1999) ArticleTitleTranscription factor decoy to study the molecular mechanism of negative regulation of renin gene expression in the liver in vivo Circ Res 84 1059–66 Occurrence Handle10325243 Occurrence Handle1:CAS:528:DyaK1MXjtFCjt74%3D
R Morishita GH Gibbons RE Pratt N Tomita Y Kaneda T Ogihara et al. (1994) ArticleTitleAutocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth J Clin Invest 94 824–9 Occurrence Handle8040338 Occurrence Handle1:CAS:528:DyaK2cXlsV2qur4%3D
R Morishita GH Gibbons KE Ellison M Nakajima L Zhang Y Kaneda et al. (1993) ArticleTitleSingle intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia Proc Natl Acad Sci USA 90 8474–8 Occurrence Handle8104336 Occurrence Handle10.1073/pnas.90.18.8474 Occurrence Handle1:CAS:528:DyaK2cXjtlE%3D
N Tomita R Morishita J Higaki S Tomita M Aoki Y Kaneda et al. (1995) ArticleTitleEffect of angiotensinogen on blood pressure regulation in normotensive rats: application of a loss of function approach J Hypertens 13 1767–74 Occurrence Handle8903649 Occurrence Handle10.1097/00004872-199512010-00048 Occurrence Handle1:CAS:528:DyaK28XhtFGqtbk%3D
Y Kaneda Y Saeki R Morishita (1999) ArticleTitleGene therapy using HVJ-liposomes: the best of both worlds? Mol Med Today 5 298–303 Occurrence Handle10377521 Occurrence Handle10.1016/S1357-4310(99)01482-3 Occurrence Handle1:CAS:528:DyaK1MXkvFGjur0%3D
Y Kaneda K Iwai T Uchida (1989) ArticleTitleIncreased expression of DNA cointroduced with nuclear protein in adult rat liver Science 243 375–8 Occurrence Handle2911748 Occurrence Handle10.1126/science.2911748 Occurrence Handle1:CAS:528:DyaL1MXhsV2jsrc%3D
Y Kaneda K Iwai T Uchida (1989) ArticleTitleIntroduction and expression of the human insulin gene in adult rat liver J Biol Chem 264 12126–9 Occurrence Handle2663849 Occurrence Handle1:CAS:528:DyaL1MXltFShtLg%3D
N Tomita J Higaki R Morishita K Kato H Mikami Y Kaneda et al. (1992) ArticleTitleDirect in vivo gene introduction into rat kidney Biochem Biophys Res Commun 186 129–34 Occurrence Handle1321600 Occurrence Handle10.1016/S0006-291X(05)80784-3 Occurrence Handle1:CAS:528:DyaK38XltVGgtLg%3D
N Tomita J Higaki Y Kaneda H Yu R Morishita H Mikami et al. (1993) ArticleTitleHypertensive rats produced by in vivo introduction of the human renin gene Circ Res 73 898–905 Occurrence Handle8403259 Occurrence Handle1:CAS:528:DyaK2cXhs1SnsbY%3D
Y Kaneda R Morishita N Tomita (1995) ArticleTitleIncreased expression of DNA co-introduced with nuclear protein in adult rat liver J Mol Med 73 289–97 Occurrence Handle7583451 Occurrence Handle10.1007/BF00231615 Occurrence Handle1:CAS:528:DyaK2MXntFemtLk%3D
VJ Dzau MJ Mann R Morishita Y Kaneda (1996) ArticleTitleFusigenic viral liposome for gene therapy in cardiovascular diseases Proc Natl Acad Sci USA 93 11421–5 Occurrence Handle8876150 Occurrence Handle10.1073/pnas.93.21.11421 Occurrence Handle1:CAS:528:DyaK28XmtlagsLk%3D
M Aoki R Morishita J Higaki A Moriguchi S Hayashi H Matsushita et al. (1997) ArticleTitleSurvival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the beta-galactosidase gene in the noninfarcted area, but not the myocardial infarcted area Gene Ther 4 120–7 Occurrence Handle9081702 Occurrence Handle10.1038/sj.gt.3300361 Occurrence Handle1:CAS:528:DyaK2sXht1GjtL0%3D
R Morishita GH Gibbons Y Kaneda T Ogihara VJ Dzau (1994) ArticleTitlePharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery Gene 149 13–9 Occurrence Handle7958977 Occurrence Handle10.1016/0378-1119(94)90406-5 Occurrence Handle1:CAS:528:DyaK2MXitFOlsrk%3D
N Tomita R Morishita J Higaki M Aoki H Mikami A Fukamizu et al. (1995) ArticleTitleTransient decrease in high blood pressure by in vivo transfer of antisense oligodeoxy- nucleotides against rat angiotensinogen Hypertension 26 131–6 Occurrence Handle7541778 Occurrence Handle1:CAS:528:DyaK2MXnsF2lurs%3D
HJ Kim JF Greenleaf RR Kinnick JT Bronk ME Bolander (1996) ArticleTitleUltrasound-mediated transfection of mammalian cells Hum Gene Ther 7 1339–46 Occurrence Handle8818721 Occurrence Handle1:CAS:528:DyaK28XltVeiurw%3D
S Bao BD Thrall DL Miller (1997) ArticleTitleTransfection of a reporter plasmid into cultured cells by sonoporation in vitro Ultrasound Med Biol 23 953–9 Occurrence Handle9300999 Occurrence Handle10.1016/S0301-5629(97)00025-2 Occurrence Handle1:STN:280:DyaK2svks1Cisw%3D%3D
U Lauer E Burgelt Z Sqiure K Messmer PH Hofschneider M Gregor et al. (1997) ArticleTitleShockwave permeabilization as a new gene transfer method Gene Ther 4 710–5 Occurrence Handle9282172 Occurrence Handle10.1038/sj.gt.3300462 Occurrence Handle1:CAS:528:DyaK2sXks1ahsb0%3D
DB Tata F Dunn DJ Tindall (1997) ArticleTitleSelective clinical ultrasound signals mediate differential gene transfer and expression in two human prostate cancer cells lines; Ln Cap and PC-3 Biochem Biophys Res Commun 234 64–7 Occurrence Handle9168961 Occurrence Handle10.1006/bbrc.1997.6578 Occurrence Handle1:CAS:528:DyaK2sXjt1ynsrg%3D
JA Wyber J Andrews A D'Emanuele (1997) ArticleTitleThe use of sonocation for the efficient delivery of plasmid DNA into cells Pharm Res 14 750–6 Occurrence Handle9210192 Occurrence Handle10.1023/A:1012198321879 Occurrence Handle1:CAS:528:DyaK2sXkt1yit7k%3D
K Tachibana T Uchida K Ogawa N Yamashita K Tamura (1999) ArticleTitleInduction of cell-membrane porosity by ultrasound Lancet 353 1409 Occurrence Handle10227224 Occurrence Handle10.1016/S0140-6736(99)01244-1 Occurrence Handle1:STN:280:DyaK1M3ktFOlsQ%3D%3D
S Bao B Thrall RA Gies LD Miller (1998) ArticleTitleIn vivo transfection of melanoma cells by lithotripter shock waves Cancer Res 58 219–21 Occurrence Handle9443395 Occurrence Handle1:STN:280:DyaK1c7gtlKgsA%3D%3D
K Anwer G Kao B Proctor I Anscombe V Florack R Earls et al. (2000) ArticleTitleUltrasound enhancement of cationic lipid-mediated gene transfer to primary tumors following systemic administration Gene Ther 7 1833–9 Occurrence Handle11110415 Occurrence Handle10.1038/sj.gt.3301302 Occurrence Handle1:CAS:528:DC%2BD3cXotFaitbg%3D
PE Huber P Pfisterer (2000) ArticleTitleIn vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound Gene Ther 7 1516–25 Occurrence Handle11001372 Occurrence Handle10.1038/sj.gt.3301242 Occurrence Handle1:CAS:528:DC%2BD3cXmsVyitLY%3D
Y Manome M Nakamura T Ohno H Furuhata (2000) ArticleTitleUltrasound facilitates transfection of naked plasmid DNA into colon carcinoma cells in vitro and in vivo Hum Gene Ther 11 1521–8 Occurrence Handle10945766 Occurrence Handle10.1089/10430340050083252 Occurrence Handle1:CAS:528:DC%2BD3cXlt1Gjsb8%3D
Y Taniyama K Tachibana K Hiraoka M Aoki S Yamamoto K Matsumoto et al. (2002) ArticleTitleDevelopment of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle Gene Ther 9 372–80 Occurrence Handle11960313 Occurrence Handle10.1038/sj.gt.3301678 Occurrence Handle1:CAS:528:DC%2BD38XisFGgtbk%3D
QL Lu HD Liang T Partridge MJ Blomley (2003) ArticleTitleMicrobubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage Gene Ther 10 396–405 Occurrence Handle12601394 Occurrence Handle10.1038/sj.gt.3301913 Occurrence Handle1:CAS:528:DC%2BD3sXhsVWitr4%3D
P Schratzberger JG Kranin G Schratzberger M Silver H Ma M Kearney et al. (2002) ArticleTitleTranscutaneous ultrasound augments naked DNA transfection of skeletal muscle Mol Ther 6 576–83 Occurrence Handle12409255 Occurrence Handle10.1016/S1525-0016(02)90715-X Occurrence Handle1:CAS:528:DC%2BD38XosVGqtbg%3D
Y Taniyama K Tachibana K Hiraoka T Namba K Yamasaki N Hashiya et al. (2002) ArticleTitleLocal delivery of plasmid DNA into rat carotid artery using ultrasound Circulation 105 1233–9 Occurrence Handle11889019 Occurrence Handle10.1161/hc1002.105228 Occurrence Handle1:CAS:528:DC%2BD38XivFaqtbY%3D
H Azuma N Tomita Y Kaneda H Koike T Ogihara Y Katsuoka et al. (2003) ArticleTitleTransfection of NF kappa B-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts Gene Ther 10 415–25 Occurrence Handle12601396 Occurrence Handle10.1038/sj.gt.3301882 Occurrence Handle1:CAS:528:DC%2BD3sXhsVWisbg%3D
HY Lan W Mu N Tomita R Morishita XQ Yu JH Li et al. (2003) ArticleTitleInhibition of renal fibrosis by gene transfer of inducible Smad7 using an ultrasound–microbubble system in rat UUO model J Am Soc Nephrol 14 1535–48 Occurrence Handle12761254 Occurrence Handle10.1097/01.ASN.0000067632.04658.B8 Occurrence Handle1:CAS:528:DC%2BD3sXjslanuro%3D
H Koike N Tomita H Azuma Y Taniyama K Yamasaki Y Kunugiza et al. (2005) ArticleTitleA novel gene transfer method mediated by ultrasound and microbubbles into the kidney J Gene Med 7 108–16 Occurrence Handle15515148 Occurrence Handle10.1002/jgm.632 Occurrence Handle1:CAS:528:DC%2BD2MXhsFartb8%3D
M Tsujie Y Isaka H Nakamura E Imai M Hori (2001) ArticleTitleElectroporation-mediated gene transfer that targets glomeruli J Am Soc Nephrol 12 949–54 Occurrence Handle11316853 Occurrence Handle1:CAS:528:DC%2BD3MXjvVCgtL0%3D
H Nakamura Y Isaka M Tsujie Y Akagi T Sudo N Ohno et al. (2001) ArticleTitleElectroporation-mediated PDGF receptor-IgG chimera gene transfer ameliorates experimental glomerulonephritis Kidney Int 59 2134–45 Occurrence Handle11380815 Occurrence Handle1:CAS:528:DC%2BD3MXks1Kltb4%3D
E Imai Y Isaka (2002) ArticleTitleGene electrotransfer: potential for gene therapy of renal diseases Kidney Int 61 S37–41 Occurrence Handle10.1046/j.1523-1755.2002.0610s1037.x Occurrence Handle11841610
LJ Striker EP Peten SJ Elliot T Doi GE Striker (1991) ArticleTitleMesangial cell turnover: effect of heparin and peptide growth factors Lab Invest 64 446–56 Occurrence Handle2016850 Occurrence Handle1:CAS:528:DyaK3MXltlarsbg%3D
M Kashgarian RB Sterzel (1992) ArticleTitleThe pathobiology of the mesangium Kidney Int 41 524–9 Occurrence Handle1573822 Occurrence Handle1:STN:280:DyaK383ktlOgtA%3D%3D
HE Abbou (1993) ArticleTitleGrowth factors in glomerulonephritis Kidney Int 43 252–67
RJ Johnson H Iida A Yoshimura J Floege DF Bowen-Pope (1992) ArticleTitlePlatelet-derived growth factor and mesangial cells Kidney Int 41 581–3
S Klahr G Schreiner I Ichikawa (1988) ArticleTitleThe progression of renal diseases N Engl J Med 318 1657–66 Occurrence Handle3287163 Occurrence Handle1:STN:280:DyaL1c3jt1ygsg%3D%3D Occurrence Handle10.1056/NEJM198806233182505
J Floege E Eng BA Young RJ Johnson (1993) ArticleTitleFactors involved in the regulation of mesangial cell proliferation in vitro and in vivo Kidney Int 43 S47–54 Occurrence Handle1:CAS:528:DyaK3sXks12isLg%3D
JR Nevins (1992) ArticleTitleE2F: a link between the Rb tumor suppressor protein and viral oncoproteins Science 258 424–9 Occurrence Handle1411535 Occurrence Handle10.1126/science.1411535 Occurrence Handle1:CAS:528:DyaK3sXht1Wrs78%3D
M Pagano G Draetta P Jansen-Durr (1992) ArticleTitleAssociation of cdk2 kinase with the transcription factor E2F during S phase Science 255 1144–7 Occurrence Handle1312258 Occurrence Handle10.1126/science.1312258 Occurrence Handle1:CAS:528:DyaK38Xks1Oitb0%3D
NB La Thangue (1994) ArticleTitleDRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell cycle control Trends Biochem Sci 19 108–14 Occurrence Handle8203017 Occurrence Handle10.1016/0968-0004(94)90202-X Occurrence Handle1:CAS:528:DyaK2cXmslejsLs%3D
RJ Johnson EW Raines J Floege A Yoshimura P Pritzl C Alpers et al. (1992) ArticleTitleInhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor J Exp Med 175 1413–6 Occurrence Handle1569407 Occurrence Handle10.1084/jem.175.5.1413 Occurrence Handle1:CAS:528:DyaK38XhvFajt7w%3D
SJ Weintraub CA Prater DC Dean (1992) ArticleTitleRetinoblastoma protein switches the E2F site from positive to negative element Nature 358 259–61 Occurrence Handle1321348 Occurrence Handle10.1038/358259a0 Occurrence Handle1:CAS:528:DyaK38XltVGlsrs%3D
T Chittenden DM Livingston WG Kaelin (1992) ArticleTitleThe T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein Cell 65 1073–82 Occurrence Handle10.1016/0092-8674(91)90559-H
K Thalmeier H Synovzik R Mertz EL Winnacker M Lipp (1989) ArticleTitleNuclear factor E2F mediates basic transcription and trans-activation by E1A of the human MYC promoter Genes Dev 3 527–36 Occurrence Handle2721961 Occurrence Handle1:CAS:528:DyaL1MXktlCntbc%3D
RJ Watson PJ Dyson J McMahon (1987) ArticleTitleMultiple c-myb transcript cap sites are variously utilized in cells of mouse haemopoietic origin EMBO J 6 1643–51 Occurrence Handle3608990 Occurrence Handle1:CAS:528:DyaL2sXktlOhsLc%3D
M Yamaguchi Y Hayashi F Hirose S Matsuoka K Shiroki A Matsunaga (1992) ArticleTitleActivation of the mouse proliferating cell nuclear antigen gene promoter by adenovirus type 12 E1A proteins Jpn J Cancer Res 83 609–17 Occurrence Handle1353754 Occurrence Handle1:CAS:528:DyaK38XmtVKhs7s%3D
S Dalton (1992) ArticleTitleCell cycle regulation of the human cdc2 gene EMBO J 11 1797–804 Occurrence Handle1582409 Occurrence Handle1:CAS:528:DyaK38XktVait70%3D
DH Hooke DC Gee RC Atkins (1987) ArticleTitleLeukocyte analysis using monoclonal antibodies in human glomerulonephritis Kidney Int 31 964–72 Occurrence Handle3495689 Occurrence Handle1:STN:280:DyaL2s3islSlug%3D%3D
HL Li WW Hancock JP Dowling RC Atkins (1991) ArticleTitleActivated (IL-2R+) intraglomerular mononuclear cells in crescentic glomerulonephritis Kidney Int 39 793–8 Occurrence Handle2051738 Occurrence Handle1:STN:280:DyaK3M3mvFOjsw%3D%3D
IL Noronha C Kruger KE Andrassy R Waldherr (1993) ArticleTitleIn situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis Kidney Int 43 682–92 Occurrence Handle8455368 Occurrence Handle1:STN:280:DyaK3s3gsVChsA%3D%3D
ZI Niemir H Stein G Dworacki P Mundel N Koehl B Koch et al. (1997) ArticleTitlePodocytes are the major source of IL-1 alpha and IL-1 beta in human glomerulonephritides Kidney Int 52 393–403 Occurrence Handle9263995 Occurrence Handle1:STN:280:DyaK2svgvFKgtg%3D%3D
BH Rovin N Doe LC Tan (1996) ArticleTitleMonocyte chemoattractant protein-1 levels in patients with glomerular disease Am J Kidney Dis 27 640–6 Occurrence Handle8629622 Occurrence Handle1:STN:280:DyaK287ps1yntQ%3D%3D
GA Muller J Markovski-Lipkovski CA Muller (1991) ArticleTitleIntercellular adhesion molecule-1 expression in human kidneys with glomerulonephritis Clin Nephrol 36 203–8 Occurrence Handle1683616
GF Schreiner RS Cotran V Pardo ER Unanue (1978) ArticleTitleA mononuclear cell component in experimental immunological glomerulonephritis J Exp Med 147 369–84 Occurrence Handle146726 Occurrence Handle10.1084/jem.147.2.369 Occurrence Handle1:STN:280:DyaE1c7htVKgug%3D%3D
MJ Lenardo D Baltimore (1989) ArticleTitleNF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control Cell 58 227–9 Occurrence Handle2665943 Occurrence Handle10.1016/0092-8674(89)90833-7 Occurrence Handle1:CAS:528:DyaL1MXltFehtLw%3D
PJ Barnes M Karin (1997) ArticleTitleNuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases N Engl J Med 336 1066–71 Occurrence Handle9091804 Occurrence Handle10.1056/NEJM199704103361506 Occurrence Handle1:CAS:528:DyaK2sXis1SrsLw%3D
IJ Moon K Choi YK Choi JE Kim Y Lee AD Schreiber et al. (2000) ArticleTitlePotent growth inhibition of leukemic cells by novel ribbon-type antisense oligonucleotides to c-myb1 J Biol Chem 275 4647–53 Occurrence Handle10671493 Occurrence Handle10.1074/jbc.275.7.4647 Occurrence Handle1:CAS:528:DC%2BD3cXhsVynurw%3D
T Hosoya H Takeuchi Y Kanesaka H Yamakawa N Miyano-Kurosaki K Takai et al. (1999) ArticleTitleSequence-specific inhibition of a transcription factor by circular dumbbell DNA oligonucleotides FEBS Lett 461 136–40 Occurrence Handle10567684 Occurrence Handle10.1016/S0014-5793(99)01450-7 Occurrence Handle1:CAS:528:DyaK1MXntlels7w%3D
WY Gao FS Han C Storm W Egan YC Cheng (1992) ArticleTitlePhosphorothioate oligodeoxy-nucleotides are inhibitors of human DNA polymerase and Rnase H: Implications for antisense technology Mol Pharmacol 41 223–9 Occurrence Handle1371582 Occurrence Handle1:CAS:528:DyaK3sXltVygtbo%3D
DA Brown SH Kang SM Gryazov L Dedionisio O Heidenreich S Sullivian et al. (1994) ArticleTitleEffect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding J Biol Chem 269 26801–5 Occurrence Handle7929417 Occurrence Handle1:CAS:528:DyaK2cXmslClsb0%3D
TL Burgress FF Fisher SL Ross JV Bready YX Qian LA Baywitch et al. (1995) ArticleTitleThe antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism Proc Natl Acad Sci USA 92 4051–5 Occurrence Handle10.1073/pnas.92.9.4051
BCF Chu L Orgal (1992) ArticleTitleThe stability of different forms of double-stranded decoy DNA in serum and nuclear extracts Nucleic Acids Res 20 5857–8 Occurrence Handle1454556 Occurrence Handle10.1093/nar/20.21.5857 Occurrence Handle1:CAS:528:DyaK3sXhvVWgtw%3D%3D
T Abe K Takai S Nakada T Yokota H Takaku (1998) ArticleTitleSpecific inhibition of influenza virus RNA polymerase and nucleoprotein gene expression by circular dumbbell RNA/DNA chimeric oligonucleotides containing antisense phosphodiester oligonucleotides FEBS Lett 425 91–6 Occurrence Handle9541013 Occurrence Handle10.1016/S0014-5793(98)00206-3 Occurrence Handle1:CAS:528:DyaK1cXhs1Gisrw%3D
N Tomita K Yuyama T Tougan T Tajima T Ogihara R Morishita (2003) ArticleTitleDevelopment of novel decoy oligonucleotides: advantages of circular dumbbell decoy Curr Opin Mol Ther 5 107–12 Occurrence Handle12772498 Occurrence Handle1:CAS:528:DC%2BD3sXkslCqurY%3D
JD Ahn R Morishita Y Kaneda SJ Lee KY Kwon SY Choi et al. (2002) ArticleTitleInhibitory effects of novel AP-1 decoy oligodeoxynucleotides on vascular smooth muscle cell proliferation in vitro and neointimal formation in vivo Circ Res 90 1325–32 Occurrence Handle12089071 Occurrence Handle10.1161/01.RES.0000023200.19316.D5 Occurrence Handle1:CAS:528:DC%2BD38XltVOqu78%3D
JD Ahn R Morishita Y Kaneda HS Kim YC Chang KU Lee et al. (2002) ArticleTitleNovel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia Gene Ther 24 1682–92 Occurrence Handle10.1038/sj.gt.3301849 Occurrence Handle1:CAS:528:DC%2BD38XptFCisLk%3D
WF Anderson (1992) ArticleTitleHuman gene therapy Science 256 808–13 Occurrence Handle1589762 Occurrence Handle10.1126/science.1589762 Occurrence Handle1:STN:280:DyaK383ntFajsg%3D%3D
AD Miller (1992) ArticleTitleHuman gene therapy comes of age Nature 357 455–60 Occurrence Handle1608446 Occurrence Handle10.1038/357455a0 Occurrence Handle1:STN:280:DyaK38zgtFGhuw%3D%3D
MJ Mann AD Whittemore MC Donaldson M Belkin MS Conte JF Polak et al. (1999) ArticleTitleEx-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomized, controlled trial Lancet 354 1493–8 Occurrence Handle10551494 Occurrence Handle10.1016/S0140-6736(99)09405-2 Occurrence Handle1:CAS:528:DyaK1MXns1Sgs70%3D
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Tomita, N., Kashihara, N. & Morishita, R. Transcription factor decoy oligonucleotide-based therapeutic strategy for renal disease. Clin Exp Nephrol 11, 7–17 (2007). https://doi.org/10.1007/s10157-007-0459-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-007-0459-6